April 11 - 14, 2022
Free-to-Attend 4-day Webcast Series // Pre-Recorded,
Presented in Japan Standard Time // Antibody Focus Day April 14 2022
THE ONLY EVENT IN ASIA PROVIDING THE LATEST SCIENCE, TECHNOLOGY AND PARTNERS TO ACCELERATE ANTIBODY & PROTEIN THERAPIES, ADCS, BISPECIFICS AND IMMUNO-ONCOLOGY
World-renowned scientists sharing the latest technologies, R&D and clinical data to fast-track your next-generation therapeutics towards commercial success
A 1-DAY DEDICATED WEBCAST SERIES DEDICATED TO BRINGING YOU THE LATEST KNOWLEDGE IN THE ANTIBODY AND PROTEIN COMMUNITY
Free Webcast Series
Antibody Engineering & Therapeutics ASIA is free to attend. You will learn from 3 keynote industry speakers, several cutting-edge technology companies and CRO speakers who will present some of the latest antibody engineering, discovery and R&D developments in the field. Antibody Engineering & Therapeutics ASIA is not a virtual conference.
All speaker presentations are pre-recorded and will run as a series of webinars on JST (Japan Standard Time). The webinars will also be available on-demand post-event for anyone with a scheduling conflict, so be sure to still sign up!
Add-on Training Course
Introduction to Antibody Engineering
April 19-21 Japan time 9:00am-11:30am (JST)
Back for 2022 by popular demand, you will once again have the option to purchase a limited space to the popular training course, Introduction to Antibody Engineering. Whether you need a refresher on antibody engineering concepts and applications, are new to the field or have new responsibilities in antibody/protein engineering & therapeutics-related department, you will find this popular course extremely helpful!
Delivered over 3 days in easily digestible 2.5-hour modules from 9:00 - 11:30 am (JST). Whatever your need, the knowledge gained from this comprehensive training course is invaluable. After completion of training course, you will receive a digital badge to place on your social media accounts or on your resume.
More details on pricing coming soon.
Session Themes Include:
- Antibody Selection and Screening and Antibody Affinity Maturation
- Therapeutic Targets for Antibodies
- Bispecifics, ADCs, Immune-Oncology and CAR T-cells
- Improving Antibody Properties
- Antibody Structure Insights
- New Developments in Antibody R&D